The acquisition will see Sigma-Aldrich merged with the Merck Milipore business, which the company says will create an undisputed leader in the $130 billion global life sciences services industry.
Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...
Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is expected to be finalized by the end of 2024, according to a Dec ...
Millipore Sigma, the US and Canadian life sciences branch of Germany-based Merck KGaA, opened the roughly $300 million facility in October 2024 to focus on "biosafety testing, analytical ...
The Life Science business of Merck KGaA, Darmstadt, Germany, has acquired HUB Organoids B.V. (HUB), as announced by ...
BURLINGTON - MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, recently confirmed that the Life Science business of Merck KGaA, Darmstadt, Germany has signed ...
BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that the Life Science business of Merck KGaA, Darmstadt ...